Goodheart MJ - Search Results

1

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.

Salinas EA, Miller MD, Newtson AM, Sharma D, McDonald ME, Keeney ME, Smith BJ, Bender DP, Goodheart MJ, Thiel KW, Devor EJ, Leslie KK, Gonzalez Bosquet J. Salinas EA, et al. Among authors: goodheart mj. Int J Mol Sci. 2019 Mar 9;20(5):1205. doi: 10.3390/ijms20051205. Int J Mol Sci. 2019. PMID: 30857319 Free PMC article.

2

In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy.

Corvigno S, Badal S, Spradlin ML, Keating M, Pereira I, Stur E, Bayraktar E, Foster KI, Bateman NW, Barakat W, Darcy KM, Conrads TP, Maxwell GL, Lorenzi PL, Lutgendorf SK, Wen Y, Zhao L, Thaker PH, Goodheart MJ, Liu J, Fleming N, Lee S, Eberlin LS, Sood AK. Corvigno S, et al. Among authors: goodheart mj. NPJ Precis Oncol. 2023 Nov 3;7(1):115. doi: 10.1038/s41698-023-00454-0. NPJ Precis Oncol. 2023. PMID: 37923835 Free PMC article.

3

p21 expression predicts outcome in p53-null ovarian carcinoma.

Rose SL, Goodheart MJ, DeYoung BR, Smith BJ, Buller RE. Rose SL, et al. Among authors: goodheart mj. Clin Cancer Res. 2003 Mar;9(3):1028-32. Clin Cancer Res. 2003. PMID: 12631602

4

The influence of microvessel density on ovarian carcinogenesis.

Stone PJ, Goodheart MJ, Rose SL, Smith BJ, DeYoung BR, Buller RE. Stone PJ, et al. Among authors: goodheart mj. Gynecol Oncol. 2003 Sep;90(3):566-71. doi: 10.1016/s0090-8258(03)00367-6. Gynecol Oncol. 2003. PMID: 13678725

5

The impact of p53 protein core domain structural alteration on ovarian cancer survival.

Rose SL, Robertson AD, Goodheart MJ, Smith BJ, DeYoung BR, Buller RE. Rose SL, et al. Among authors: goodheart mj. Clin Cancer Res. 2003 Sep 15;9(11):4139-44. Clin Cancer Res. 2003. PMID: 14519637

6

Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.

Jacobson GM, Kamath RS, Smith BJ, Goodheart MJ. Jacobson GM, et al. Among authors: goodheart mj. Gynecol Oncol. 2005 Feb;96(2):470-4. doi: 10.1016/j.ygyno.2004.10.023. Gynecol Oncol. 2005. PMID: 15661237

7

Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity.

Goodheart M, Jacobson G, Smith BJ, Zhou L. Goodheart M, et al. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):95-103. doi: 10.1111/j.1525-1438.2007.00967.x. Epub 2007 Apr 26. Int J Gynecol Cancer. 2008. PMID: 17466049

8

BRCA2 alteration is important in clear cell carcinoma of the ovary.

Goodheart MJ, Rose SL, Hattermann-Zogg M, Smith BJ, De Young BR, Buller RE. Goodheart MJ, et al. Clin Genet. 2009 Aug;76(2):161-7. doi: 10.1111/j.1399-0004.2009.01207.x. Epub 2009 Jul 28. Clin Genet. 2009. PMID: 19656163

9

Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.

Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G, Clevenger L, Lubaroff DM, Sood AK, Cole SW. Lutgendorf SK, et al. Brain Behav Immun. 2011 Feb;25(2):250-5. doi: 10.1016/j.bbi.2010.10.012. Epub 2010 Oct 16. Brain Behav Immun. 2011. PMID: 20955777 Free PMC article.

10

A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival.

Shamshirsaz AA, Buekers T, Degeest K, Bender D, Zamba G, Goodheart MJ. Shamshirsaz AA, et al. Among authors: goodheart mj. Int J Gynecol Cancer. 2011 Oct;21(7):1232-40. doi: 10.1097/IGC.0b013e318220fc46. Int J Gynecol Cancer. 2011. PMID: 21720254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters